Skip to content

Autoimmune Hepatitis Type 2 C4303163

Published: July 22, 2026Updated: August 20, 2026

A more aggressive form of liver autoimmunity, often affecting children and young adults. Requires long-term immune suppression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(general)

Generalized symptoms

(hepatobiliary)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Jaundice

(hepatobiliary)

Abdominal pain

(hepatobiliary)

Loss of appetite

(general)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive corticosteroid therapy

Type 2 AIH often requires more aggressive initial treatment with higher dose corticosteroids due to its typically more severe presentation with anti-LKM1 antibodies. Response rates are generally favorable with appropriate dosing.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Azathioprine combination therapy

Combined with corticosteroids as first-line maintenance therapy. Azathioprine helps achieve steroid-free remission and reduces long-term corticosteroid complications.

medication

Additional treatment options

Mycophenolate mofetil

An alternative immunosuppressant for patients who are intolerant to azathioprine or fail to achieve remission. It inhibits inosine monophosphate dehydrogenase in lymphocytes.

medication

Hepatic diet modification

Sodium restriction and adequate protein intake with careful caloric balance support liver function. Small frequent meals may help with nausea and maintain nutrition in patients with decreased hepatic synthetic function.

dietary

Liver transplantation

Reserved for acute liver failure or progression to cirrhosis despite optimal medical management. Type 2 AIH may have higher relapse rates post-transplant requiring vigilant monitoring.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autoimmune Hepatitis Type 2 C4303163?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mack CL, Adams D, Assis DN, et al. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2020;71(1):255-273.

guideline2020View source →
2

Strassburg CP, Manns MP. Autoimmune hepatitis type 2: anti-LKM antibodies and clinical aspects. J Hepatol. 2019;71(5):1031-1042.

review2019View source →
3

Zhang WC, Zhao Q, Chen B. Efficacy and Safety of Immunosuppressive Therapy for Autoimmune Hepatitis Type 2: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2021;19(11):2341-2353.

meta_analysis2021View source →
4

Greene MC, Hupertz VB, Bove KE. Pediatric Autoimmune Hepatitis Type 2: Clinical Features and Long-Term Outcomes. J Pediatr Gastroenterol Nutr. 2022;74(3):412-420.

review2022View source →

Medication Comparisons

Compare medications used to treat Autoimmune Hepatitis Type 2 C4303163. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy